Drug News
-
Fosun Pharma’s Global Initiative Receives 500 Million JPY Investment from GHIT Fund to Combat Malaria
In a groundbreaking move, the Global Health Innovative Technology Fund (GHIT Fund), based in Japan, has pledged approximately US$3.3 million…
Read More » -
AstraZeneca Expands Vaccine Portfolio with $1.1 Billion Acquisition of Icosavax
AstraZeneca, a global pharmaceutical giant, announced on Tuesday its strategic move to acquire respiratory syncytial virus (RSV) vaccine developer Icosavax…
Read More » -
U.S. Employers Turn to Virtual Providers to Manage Rising Costs of Weight-Loss Drug
Facing escalating expenses linked to obesity drugs such as Novo Nordisk’s Wegovy, U.S. employers are adopting virtual healthcare providers like…
Read More » -
U.S. Supreme Court to Rule on Abortion Pill Access
In a decision that could significantly impact reproductive rights in the United States, the U.S. Supreme Court has agreed to…
Read More » -
Pfizer Faces Investor Backlash as 2024 COVID Sales Projection Plummets, Shares Hit a Decade Low
In a surprising turn of events, Pfizer, one of the leading pharmaceutical giants, has sent shockwaves through the market as…
Read More » -
APCI Applauds House Passage of Lower Costs Act, Urges Ongoing PBM Reform
American Pharmacy Cooperative, Inc. (APCI) expressed appreciation for the House of Representatives’ passage of the Lower Costs, More Transparency Act…
Read More » -
Dizal’s Sunvozertinib Shows Promise in Pivotal Study for Non-Small-Cell Lung Cancer
Dizal Pharmaceutical has announced a major breakthrough in the treatment of platinum-pretreated non-small-cell lung cancer (NSCLC) patients with EGFR exon…
Read More » -
Acesion Pharma’s Breakthrough in Atrial Fibrillation Treatment Published in Nature Medicine
In a groundbreaking development in the field of cardiac arrhythmia, Acesion Pharma, a biotech company specializing in novel therapies for…
Read More » -
Cipla Initiates Voluntary Recall of Vigabatrin for Oral Solution Due to Seal Integrity Issues
Cipla Limited, a global pharmaceutical company, has announced the voluntary recall of one lot of Vigabatrin for Oral Solution, USP…
Read More » -
Global Gene Therapy Market Expected to Surge by USD 4,613.9 Million from 2022 to 2027
The global gene therapy market is anticipated to witness substantial growth, with Technavio projecting a robust increase of USD 4,613.9…
Read More »